NDC 47781-405

Rivastigmine Transdermal System

Rivastigmine Transdermal System

Rivastigmine Transdermal System is a Transdermal Patch, Extended Release in the Human Prescription Drug category. It is labeled and distributed by Alvogen Inc.. The primary component is Rivastigmine.

Product ID47781-405_07f534f5-5146-8b12-29b5-5a4992e43412
NDC47781-405
Product TypeHuman Prescription Drug
Proprietary NameRivastigmine Transdermal System
Generic NameRivastigmine Transdermal System
Dosage FormPatch, Extended Release
Route of AdministrationTRANSDERMAL
Marketing Start Date2015-09-02
Marketing CategoryANDA / ANDA
Application NumberANDA204403
Labeler NameAlvogen Inc.
Substance NameRIVASTIGMINE
Active Ingredient Strength13 mg/1
Pharm ClassesCholinesterase Inhibitor [EPC],Cholinesterase Inhibitors [MoA]
NDC Exclude FlagN
Listing Certified Through2019-12-31

Packaging

NDC 47781-405-03

30 POUCH in 1 CARTON (47781-405-03) > 1 PATCH, EXTENDED RELEASE in 1 POUCH (47781-405-11)
Marketing Start Date2015-09-02
NDC Exclude FlagN
Sample Package?N

NDC SPL Data Element Entries

NDC 47781-405-11 [47781040511]

Rivastigmine Transdermal System PATCH, EXTENDED RELEASE
Marketing CategoryANDA
Application NumberANDA204403
Product TypeHUMAN PRESCRIPTION DRUG
Billing UnitEA
Marketing Start Date2015-09-02

NDC 47781-405-03 [47781040503]

Rivastigmine Transdermal System PATCH, EXTENDED RELEASE
Marketing CategoryANDA
Application NumberANDA204403
Product TypeHUMAN PRESCRIPTION DRUG
Billing UnitEA
Marketing Start Date2015-09-02

Drug Details

Active Ingredients

IngredientStrength
RIVASTIGMINE13.3 mg/1

OpenFDA Data

SPL SET ID:11d4ef03-33d2-359e-2053-4102630b27ba
Manufacturer
UNII
RxNorm Concept Unique ID - RxCUI
  • 725021
  • 725023
  • 1308569
    • UPC Code
  • 0347781405113
  • 0347781305031
  • 0347781405038
  • 0347781304119
  • 0347781305116
  • 0347781304034

    • Pharmacological Class

    • Cholinesterase Inhibitor [EPC]
    • Cholinesterase Inhibitors [MoA]

    Medicade Reported Pricing

    47781040511 RIVASTIGMINE 13.3 MG/24HR PTCH

    Pricing Unit: EA | Drug Type:

    47781040503 RIVASTIGMINE 13.3 MG/24HR PTCH

    Pricing Unit: EA | Drug Type:

    NDC Crossover Matching brand name "Rivastigmine Transdermal System" or generic name "Rivastigmine Transdermal System"

    NDCBrand NameGeneric Name
    47781-304Rivastigmine Transdermal SystemRivastigmine Transdermal System
    47781-305Rivastigmine Transdermal SystemRivastigmine Transdermal System
    47781-405Rivastigmine Transdermal SystemRivastigmine Transdermal System
    51991-897Rivastigmine Transdermal SystemRivastigmine
    51991-898Rivastigmine Transdermal SystemRivastigmine
    51991-899Rivastigmine Transdermal SystemRivastigmine
    63629-2064Rivastigmine Transdermal SystemRivastigmine
    63629-2065Rivastigmine Transdermal SystemRivastigmine
    63629-2066Rivastigmine Transdermal SystemRivastigmine
    63629-8807Rivastigmine Transdermal SystemRivastigmine
    63629-8846Rivastigmine Transdermal SystemRivastigmine
    72855-100Rivastigmine Transdermal SystemRivastigmine
    72855-102Rivastigmine Transdermal SystemRivastigmine Transdermal System
    72855-101Rivastigmine Transdermal SystemRivastigmine Transdermal System
    © 2024 FDA.report
    This site is not affiliated with or endorsed by the FDA.